C-Arm Devices Market Will Generate Booming Growth Opportunities to 2032

The utilization of C-arm devices is expected to rise due to their ability to provide high-resolution X-ray images in real-time, enabling clinicians to monitor progress throughout surgeries.

The global C-arm devices market was valued at US$ 1.7 billion in 2019, and it is projected to reach US$ 2.45 billion by 2027, with a Compound Annual Growth Rate (CAGR) of 4.2% between 2022 and 2032.

The North American C-arm device market is anticipated to have a substantial share owing to a high frequency of diagnostic testing, an aging population, and a growing incidence of chronic illnesses. The United States, in particular, is experiencing a strong demand for C-arm devices due to increased medical imaging technology expertise, financial stability to purchase expensive devices, and acceptance of innovative products. Additionally, the country's growing investment in medical and healthcare infrastructure serves as a boost for C-arm device sales.

Following North America, the Asia Pacific C-arm devices market is predicted to experience the fastest CAGR, driven by increasing demand in diagnostic and interventional radiology procedures. The presence of established hospitals and a large target customer base are expected to drive C-arm device sales in China. Meanwhile, in India, rising population awareness and rapid medical tourism are likely to boost C-arm device sales in the Asia-Pacific region.

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: GE Healthcare Inc., Philips Healthcare, Siemens AG, Hologic corp., BMI Biomedical International s.r.l., DMS Health Technologies, Medonica Co., Ltd., Gemss Co. Ltd., Shimadzu Corp.

Browse More@ https://www.futuremarketinsights.com/reports/c-arms-devices-market

Segmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

By Type:

  • Fixed C-Arms
  • Mobile C-Arms

By Application:

  • Cardiology
  • Gastroenterology
  • Neurology
  • Orthopaedics and Trauma
  • Oncology
  • Other Applications

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more